“To further improve the path of patients with lung cancer, we need to make the country even more attractive with respect to innovation. This can be done by generating more resources around the patient himself, so the opportunity to increase the Fund is welcome It would then be desirable for all innovation to be recognized as such by making full use of the Innovative Medicines Fund, so that all patients can have rapid access to innovation and greater life expectancy in good health.” . This was stated by Nicoletta Luppi, president and managing director of MSD Italia, today in Milan on the sidelines of the presentation of the results of the study phase of the project ‘The importance of the public-private partnership in the management of cancer patients’, the result of the partnership between the Foundation Irccs National Cancer Institute (Int) of Milan, MSD Italia and the School of management of the Polytechnic of Milan.
“We present a partnership that is truly strategic because at the center there is the new and innovative value that will be generated by the patient, but behind it there is an extraordinary collaboration that will allow us to bring together all the mutual skills, experiences and skills relating to the patient himself – continues Luppi – The objective is to generate a new treatment path that can create more value and therefore more life and more quality of life for all patients who will have the opportunity to be included in this path”.
The project included a first phase of in-depth analysis of the current state of the processes for taking charge and managing patients with lung cancer, from which it emerged that the Milan Int is positioned as a reference center at a national level, with 1,900 annual visits for lung cancer, of which over half come from regions other than Lombardy. The partnership aims to optimize the processes of early taking charge and management of the patient in order to achieve a timely diagnosis of the disease, as well as the implementation of an effective treatment path capable of responding to the needs of the patient and the own caregiver.
#Luppi #MSD #Fund #innovators #fully #exploited